Toni Weinschenk

Företagsledare/Principal på IMMATICS N.V.

Förmögenhet: - $ per 2026-05-31

56 år

Health Technology

Consumer Services

Profil

Toni Weinschenk is the founder of Immatics Biotechnologies GmbH, founded in 2000, holding the title of Chief Innovation Officer since 2020.
Dr. Weinschenk is the founder of Immatics US, Inc., founded in 2015, holding the title of Chief Technology Officer since 2015.
Dr. Weinschenk currently holds the position of Chief Innovation Officer at Immatics NV since 2020.
Dr. Weinschenk earned a doctorate from Eberhard Karls Universität Tübingen.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
IMMATICS N.V. -.--%	2026-03-18	0 ( -.--% )	- $	2026-05-31

Aktiva positioner av Toni Weinschenk

Företag	Position	Start
IMMATICS N.V.	Företagsledare/Principal	2020-01-01
Immatics Biotechnologies GmbH Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer	Grundare	2000-01-01
Immatics US, Inc. Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer	Grundare	2015-06-01

Alla aktiva positioner av Toni Weinschenk

Toni Weinschenks utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Toni Weinschenks erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Immatics Biotechnologies GmbH Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer	Health Technology
Eberhard Karls Universität Tübingen Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Immatics US, Inc. Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer	Health Technology
Immatics NV Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments	Health Technology